Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.7.0.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2017
Significant Accounting Policies Tables  
Concentrations of credit risk

Concentration of Risk        
    Three and six months ended June 30,  
    2017   2016  
Revenue Concentration        
Medicare     35.0 %     30.0 %  
Commercial Payor 1     22.0 %     21.0 %  
                   
      June 30,       Dec 31,      
      2017       2016    
Receivable Concentration                  
Medicare     34.6 %     27.0 %  
Commercial Payor 1     15.5 %     19.8 %  
Commercial Payor 2     12.4 %     11.9 %  

Net (loss) income per share

    Three months ended June 30,   Six months ended June 30,
    2017   2016   2017   2016
Numerator:                
Net (loss) income   $ (131,575 )   $ 153,137     $ 70,944     $ 9,720,078  
                                 
Denominator:                                
Weighted-average common shares, basic     26,843,848       23,862,943       26,549,810       23,374,625  
Weighted-average common shares, diluted     26,843,848       27,196,277       27,349,810       26,707,959  
                                 
Basic:   $ (0.00 )   $ 0.01     $ 0.00     $ 0.42  

 

    June 30,
    2017   2016
Convertible line of credit     800,000        
Warrants to purchase common stock     1,875,000       4,324,630  
Options to purchase common stock     3,000,000       3,000,000  
Restricted stock awards     660,000       150.000  
      6,335,000       7,474,630